C-P Hsu

Simulations Using a Drug–Disease Modeling Framework and Phase II Data Predict Phase III Survival Outcome in First-Line Non–Small-Cell Lung Cancer

Laurent Claret, Jyh‐Feng Lu, René Bruno et al. · Clinical Pharmacology & Therapeutics · 2012 · 34 citations

Medicine, Oncology, Pharmacology +13

Concordant expression of the telomerase-associated genes in non-small cell lung cancer

C-P Hsu, Jen Miaw, Jiun‐Yi Hsia et al. · European Journal of Surgical Oncology · 2003 · 30 citations

Medicine, Molecular Biology, Oncology +16

Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients With Non–Small Cell Lung Cancer Based on MONET1 Study Results

Laurent Claret, René Bruno, Jyh‐Feng Lu et al. · Clinical Pharmacology & Therapeutics · 2014 · 19 citations

Medicine, Biostatistics, Oncology +17

Prognostic impact of circumferential resection margin in esophageal cancer with or without neoadjuvant chemoradiotherapy

P-K Hsu, H-S Hsu, Y-C Wu et al. · Diseases of the Esophagus · 2020 · 11 citations

Medicine, Oncology, Surgery +16